Banque Transatlantique’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.3M Buy
914,874
+115,967
+15% +$6.3M 1.53% 14
2026
Q1
$50.2M Sell
798,907
-412,424
-34% -$33M 1.2% 21
2025
Q4
$115M Buy
1,211,331
+139,431
+13% +$13.7M 2.8% 10
2025
Q3
$104M Buy
1,071,900
+144,422
+16% +$15M 2.55% 10
2025
Q2
$99.8M Buy
927,478
+108,550
+13% +$11M 2.75% 11
2025
Q1
$82.6M Buy
818,928
+167,069
+26% +$16.8M 2.5% 11
2024
Q4
$57.3M Buy
+651,859
New +$57.4M 1.46% 18

Other funds holding BSX

Banque Transatlantique's BSX Position: Q2 2026 in Review

Banque Transatlantique increased its Boston Scientific (BSX) stake by 15% in Q2 2026, buying an estimated $6.3M and bringing the position to 914,874 shares worth $71.3M. The position accounts for 1.53% of the portfolio, ranked #14.

Banque Transatlantique first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $115M in Q4 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Banque Transatlantique held 914,874 shares of Boston Scientific worth $71.3M as of Q2 2026.
  • Banque Transatlantique bought 115,967 Boston Scientific shares in Q2 2026, an estimated $6.3M.
  • Boston Scientific made up 1.53% of Banque Transatlantique's portfolio in Q2 2026, its #14 holding.
  • Banque Transatlantique first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Boston Scientific position peaked at $115M in Q4 2025.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.